Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Franz Lehner

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Intensive Care Medicine Experimental|January 26, 2026
Contemporary methods for ancient problems: AI for AKIGeorg Franz Lehner, Timo Mayerhöfer, Fabian Perschinka, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 24, 2025
[Vasoactive agents in septic shock-individualized strategies]Georg Franz Lehner, Timo Mayerhöfer, Fabian Perschinka, et al.
Rheumatology (Oxford, England)|January 22, 2014
Maintenance of rituximab treatment in a patient with primary Sjögren's syndromeGeorg Franz Lehner, Malgorzata Brunner-Palka, Thomas Rettenbacher, et al.
Infection|March 19, 2022
Immunologic response in bacterial sepsis is different from that in COVID-19 sepsisFabian Perschinka, Timo Mayerhöfer, Georg Franz Lehner, et al.
Critical Care (London, England)|November 24, 2020
Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19Georg Franz Lehner, Sebastian Johann Klein, Heinz Zoller, et al.
Annals of Intensive Care|September 6, 2017
Hemofiltration induces generation of leukocyte-derived CD31+/CD41- microvesicles in sepsisGeorg Franz Lehner, Ulrich Harler, Clemens Feistritzer, et al.
Annals of Intensive Care|April 23, 2021
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulationPaul Köglberger, Sebastian J Klein, Georg Franz Lehner, et al.
Critical Care (London, England)|November 24, 2023
Safety of interhospital transfer for critically ill COVID-19 patientsFabian Perschinka, Helmut Niedermoser, Andreas Peer, et al.
Shock (Augusta, Ga.)|May 21, 2016
Characterization of Microvesicles in Septic Shock Using High-Sensitivity Flow CytometryGeorg Franz Lehner, Ulrich Harler, Viktoria Maria Haller, et al.
Viruses|July 30, 2025
Soluble Neuropilin-1 as a Marker for Distinguishing Bacterial and Viral Sepsis in Critically Ill Patients-A Prospective, Multicenter, Observational StudyFabian Perschinka, Georg Franz Lehner, Timo Mayerhöfer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Intensive Care Medicine Experimental|January 26, 2026
Contemporary methods for ancient problems: AI for AKIGeorg Franz Lehner, Timo Mayerhöfer, Fabian Perschinka, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 24, 2025
[Vasoactive agents in septic shock-individualized strategies]Georg Franz Lehner, Timo Mayerhöfer, Fabian Perschinka, et al.
Rheumatology (Oxford, England)|January 22, 2014
Maintenance of rituximab treatment in a patient with primary Sjögren's syndromeGeorg Franz Lehner, Malgorzata Brunner-Palka, Thomas Rettenbacher, et al.
Infection|March 19, 2022
Immunologic response in bacterial sepsis is different from that in COVID-19 sepsisFabian Perschinka, Timo Mayerhöfer, Georg Franz Lehner, et al.
Critical Care (London, England)|November 24, 2020
Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19Georg Franz Lehner, Sebastian Johann Klein, Heinz Zoller, et al.
Annals of Intensive Care|September 6, 2017
Hemofiltration induces generation of leukocyte-derived CD31+/CD41- microvesicles in sepsisGeorg Franz Lehner, Ulrich Harler, Clemens Feistritzer, et al.
Annals of Intensive Care|April 23, 2021
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulationPaul Köglberger, Sebastian J Klein, Georg Franz Lehner, et al.
Critical Care (London, England)|November 24, 2023
Safety of interhospital transfer for critically ill COVID-19 patientsFabian Perschinka, Helmut Niedermoser, Andreas Peer, et al.
Shock (Augusta, Ga.)|May 21, 2016
Characterization of Microvesicles in Septic Shock Using High-Sensitivity Flow CytometryGeorg Franz Lehner, Ulrich Harler, Viktoria Maria Haller, et al.
Viruses|July 30, 2025
Soluble Neuropilin-1 as a Marker for Distinguishing Bacterial and Viral Sepsis in Critically Ill Patients-A Prospective, Multicenter, Observational StudyFabian Perschinka, Georg Franz Lehner, Timo Mayerhöfer, et al.
Pageof 2